Correlation Between Vertex Pharmaceuticals and Ginkgo Bioworks
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Ginkgo Bioworks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Ginkgo Bioworks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and Ginkgo Bioworks Holdings, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Ginkgo Bioworks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Ginkgo Bioworks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Ginkgo Bioworks.
Diversification Opportunities for Vertex Pharmaceuticals and Ginkgo Bioworks
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Vertex and Ginkgo is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Ginkgo Bioworks Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ginkgo Bioworks Holdings and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Ginkgo Bioworks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ginkgo Bioworks Holdings has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Ginkgo Bioworks go up and down completely randomly.
Pair Corralation between Vertex Pharmaceuticals and Ginkgo Bioworks
Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 0.41 times more return on investment than Ginkgo Bioworks. However, Vertex Pharmaceuticals is 2.43 times less risky than Ginkgo Bioworks. It trades about -0.11 of its potential returns per unit of risk. Ginkgo Bioworks Holdings is currently generating about -0.1 per unit of risk. If you would invest 47,637 in Vertex Pharmaceuticals on August 27, 2024 and sell it today you would lose (2,540) from holding Vertex Pharmaceuticals or give up 5.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vertex Pharmaceuticals vs. Ginkgo Bioworks Holdings
Performance |
| Timeline |
| Vertex Pharmaceuticals |
| Ginkgo Bioworks Holdings |
Vertex Pharmaceuticals and Ginkgo Bioworks Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vertex Pharmaceuticals and Ginkgo Bioworks
The main advantage of trading using opposite Vertex Pharmaceuticals and Ginkgo Bioworks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Ginkgo Bioworks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will offset losses from the drop in Ginkgo Bioworks' long position.| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
| Ginkgo Bioworks vs. Eliem Therapeutics | Ginkgo Bioworks vs. HCW Biologics | Ginkgo Bioworks vs. Scpharmaceuticals | Ginkgo Bioworks vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |